Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Epstein-Barr Virus Infections × valomaciclovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Infectious Mononucleosis 1 Epstein-Barr Virus Infections 1

Interventions

Rituximab 9 Valganciclovir 6 Etoposide 4 Doxorubicin 4 Valacyclovir 3 Gemcitabine 3 Dexamethasone 3 Cyclophosphamide 3 Cisplatin 3 spartalizumab 2 pembrolizumab 2 pegaspargase 2 Zidovudine 2 Vincristine 2 Radiotherapy, Intensity-Modulated 2 Prednisone 2 Methylprednisolone 2 Methotrexate 2 Matrix-M 2 Leucovorin 2 Lenalidomide 2 Cell Count 2 Carboplatin 2 Blood Specimen Collection 2 Acyclovir 2 valomaciclovir 1 toripalimab 1 threonic acid 1 ruxolitinib 1 pomalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00575185 2017-03-22

Mono6

University of Minnesota

Phase 1/2 Completed

23 enrolled 8 charts

Infectious Mononucleosis, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡